Bone stiffness in men with type 2 diabetes mellitus

被引:23
作者
Asano, Mai [1 ]
Fukui, Michiaki [1 ]
Hosoda, Hiroko [1 ]
Shiraishi, Emi [1 ]
Harusato, Ichiko [1 ]
Kadono, Mayuko [1 ]
Tanaka, Muhei [1 ]
Hasegawa, Goji [1 ]
Yoshikawa, Toshikazu [1 ]
Nakamura, Naoto [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamigyo Ku, Kyoto 6028566, Japan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2008年 / 57卷 / 12期
关键词
D O I
10.1016/j.metabol.2008.07.025
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Osteoporosis in elderly men as well as women is increasingly recognized, and patients with type 2 diabetes mellitus have higher risk of fracture than nondiabetic subjects. The aim of the present study was to investigate the relationship between bone stiffness and serum testosterone concentration as well as other variables in men with type 2 diabetes mellitus. The relationships between bone stiffness and serum bioavailable testosterone concentrations as well as other variables including age, duration of diabetes, glycemic control (hemoglobin A(1c)), or body mass index were evaluated in 294 men with type 2 diabetes mellitus. An inverse Correlation was found between stiffness index and age. A positive correlation was found between stiffness index and serum bioavailable testosterone concentration (r = 0.231, P =.0005). Stiffness index was significantly less in current smokers (81.6 +/- 17.7) than in past smokers (86.6 +/- 17.8, P =.0396) or nonsmokers (87.7 +/- 15.2, P =.0426). Multiple regression analysis demonstrated that serum bioavailable testosterone concentration (beta=.271, P =.0006) and smoking status (beta = -0.147, P =.0408) were independent determinants of stiffness index. In conclusion, bone stiffness was associated with serum bioavailable testosterone concentration but not associated with hemoglobin A,, or duration of diabetes in men with type 2 diabetes mellitus. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1691 / 1695
页数:5
相关论文
共 39 条
[1]
TESTOSTERONE CONCENTRATIONS IN WOMEN AND MEN WITH NIDDM [J].
ANDERSSON, B ;
VERMEULEN, A ;
MARIN, P ;
BJORNTORP, P ;
LISSNER, L .
DIABETES CARE, 1994, 17 (05) :405-411
[2]
BUYSSCHAERT M, 1992, DIABETES METAB, V18, P32
[3]
Hormonal and biochemical parameters in the determination of osteoporosis in elderly men [J].
Center, JR ;
Nguyen, TV ;
Sambrook, PN ;
Eisman, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3626-3635
[4]
HIP-FRACTURES IN THE ELDERLY - A WORLDWIDE PROJECTION [J].
COOPER, C ;
CAMPION, G ;
MELTON, LJ .
OSTEOPOROSIS INTERNATIONAL, 1992, 2 (06) :285-289
[5]
Survival after hip fracture:: Short- and long-term excess mortality according to age and gender [J].
Forsén, L ;
Sogaard, AJ ;
Meyer, HE ;
Edna, TH ;
Kopjar, B .
OSTEOPOROSIS INTERNATIONAL, 1999, 10 (01) :73-78
[6]
Diabetes mellitus and the incidence of hip fracture:: results from the Nord-Trondelag Health Survey [J].
Forsén, L ;
Meyer, HE ;
Midthjell, K ;
Edna, TH .
DIABETOLOGIA, 1999, 42 (08) :920-925
[7]
OSTEOPOROSIS AND CALCIFICATION OF THE AORTA [J].
FRYE, MA ;
MELTON, LJ ;
BRYANT, SC ;
FITZPATRICK, LA ;
WAHNER, HW ;
SCHWARTZ, RS ;
RIGGS, BL .
BONE AND MINERAL, 1992, 19 (02) :185-194
[8]
Low serum testosterone concentration in middle-aged men with type 2 diabetes [J].
Fukui, Michiaki ;
Soh, Jintetsu ;
Tanaka, Muhei ;
Kitagawa, Yoshihiro ;
Hasegawa, Goji ;
Yoshikawa, Toshikazu ;
Miki, Tsuneharu ;
Nakamura, Naoto .
ENDOCRINE JOURNAL, 2007, 54 (06) :871-877
[9]
Gavin JR, 1999, DIABETES CARE, V22, pS5
[10]
MINERAL METABOLISM IN DIABETES-MELLITUS - CHANGES ACCOMPANYING TREATMENT WITH A PORTABLE SUBCUTANEOUS INSULIN INFUSION SYSTEM [J].
GERTNER, JM ;
TAMBORLANE, WV ;
HORST, RL ;
SHERWIN, RS ;
FELIG, P ;
GENEL, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (05) :862-866